Generic Clozaril

Generic Clozaril is available in tablet form and in three different strengths. The FDA has assigned an "AB" rating to it, which means that the generic medication is considered equivalent to the brand-name version. However, generic Clozaril is allowed to have different inactive ingredients (such as fillers or dyes), which may cause problems for people with certain allergies or sensitivities.

 

An Overview of Generic Clozaril

Clozaril® (clozapine) is a prescription medication that has been licensed to treat schizophrenia.
 
Clozaril is manufactured by Novartis Pharmaceuticals. However, it has since come off patent and is available as a generic.
 

Strengths of Generic Clozaril

Generic Clozaril is available in the following strengths:
 
  • Clozapine 25 mg tablets
  • Clozapine 50 mg tablets
  • Clozapine 100 mg tablets.
     

Who Makes Generic Clozaril?

The following manufacturers make generic Clozaril:
 
  • Teva Pharmaceuticals
  • Ivax Pharmaceuticals
  • Mylan Pharmaceuticals
  • Par Pharmaceutical 
  • Caraco Pharmaceutical Laboratories.
     

Is Generic Clozapine as Good as Clozaril?

All generic medications must have certain tests done to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generic versions are equivalent to the brand-name medications, and assigns a rating to each one. An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic clozapine versions currently available have an "AB" rating, meaning they are considered equivalent to Clozaril.
 
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients, which may cause problems for people with certain allergies or sensitivities.
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;